Just when you thought the markets were on a slow and steady melt up you get December starting off on the rough side. Oh well… we all know you can’t time the markets perfectly. Keep making those steady, consistent buys and hold on during those storms. Not much else you can do. With that being said, I continued making my monthly purchases, though admittedly a small one for November and I actually did not follow my own November stock considerations which is rare but on occasion happens.
I have added to my ROTH account 10 shares at $37.60 for a total investment of $376.00 in Pfizer Inc. (PFE). With this recent purchase my ROTH account holdings in PFE now totals 19 shares with a market value of $722.46. I also hold 61 shares of PFE in my taxable account with a market value of $2,319.22.
What do you think about my recent purchase? Are any health stocks on your radar for this last month of the year? Please let me know below.
Disclosure: Long PFE
14 thoughts on “Recent Stock Purchase November 2019”
Pfizer has been one I have debated since it started trading in this range. One day I need to decide between them and jnj and start a position.
keep it up!
Passivecanadianincome recently posted…Bpy – Topping up a position
Well both PFE and JNJ had some attractive entry points in recent months. Some uncertainty about PFE with the spin off coming up and JNJ has run up a bit from its recent lows. Just find that price you want and go for it.
Nice purchase DH! I am a long-term holder of PFE and love the dividend payouts each quarter. 🙂
My Dividend Dynasty recently posted…November 2019 Dividend Income
I couldn’t have commented any better. What’s not to like about a stock/company like PFE 🙂
Been a LONG time holder of PFE. It will be curious for the new company they spinoff and the dividend change-up that will happen, when that happens. Love it. Get ready for their increase towards the end of the month, as well!
I think we’re all curious to see how the spin off will affect PFE and the dividend. We’ll know soon enough. Still like the name a lot over the long haul.
Nice move. I don’t have PFE, but I do have AMGN and JNJ. A nice space to be in all told.
No shortage of strong names in the health/biotech space to choose from. It’s a great sector to own for the long haul with many short term bumps that allow us to buy on dips.
I think it is amazing that you finding time to track performance the individual companies. Have you tried to benchmark your portfolio against S&P500 mutal fund?
Financial Indepdependence recently posted…Family budget 2019 – Family budget over last 11 years.
I never did a benchmark to compare my results over any mutual fund or the market as a whole. My aim is almost exclusively income with my portfolio and not capital gains. As long as my stocks continue to churn out an ever increasing passive income stream I am happy.
Nice buy, I also have a nice number of PFE shares and looking for more. Great sustainable company with a large pipeline.
PFE seems to be a popular choice among many in the DGI community. I definitely like “health” a lot for the long haul and many great names like JNJ, AMGN, GILD, ABT, ABBV and more are there for us to choose from.
Another solid pick up Keith! Love your consistent purchases as always. I should have added some more PFE shares, but it keeps escaping me. We own 60 shares in total of PFE in our FI Portfolio and I wouldn’t mind adding a bit more or getting a bit more exposure to some of the other drug companies.
JC recently posted…Dividend Increase | Becton, Dickinson & Company (BDX)
I feel very strongly that consistency with investing is key. Keep making small or large buys every single month, ignoring the noise, while building up that passive income stream. I still like PFE going forward but may look into REITs for January.